Developing AMCP/Global Value Dossier to Demonstrate Cost and Comparative Effectiveness

AMCP/Global Value dossier is the single source document which communicates clinical, safety, economic and quality of life value proposition of medical products to payers and providers. Due to several recent market events, AMCP/global value dossier has evolved as a powerful tool to present cost and comparative effectiveness data for medical products. We recently conducted a live webinar for discussion on the following topics:

How to prepare comprehensive, concise and clear AMCP/global value dossier for drugs and devices?

How to develop and communicate budget impact model and cost effectiveness analysis using AMCP dossier/GVD?

What are AMCP's latest recommendations for developing dossier?

How to demonstrate comparative effectiveness of your products using AMCP dossier?

Using Evidence Based Medicine to develop robust and powerful AMCP dossiers/GVDs

What strategies can be implemented to easily maintain and update AMCP dossier/GVD with latest clinical and health economic information?

What type of electronic tools (e-dossier, ipad etc) can be used to present AMCP dossier/GVD?

Key findings from Novel Health survey on market access and AMCP dossier/GVD with public and private payer stakeholders

Lessons learned from NOVEL Health Strategies's experience of developing global value dossiers for some of the recently launched blockbusters

Slides from our Webinar are available here:

[NEW] NOVEL Health Strategies Selected for 13 Presentations, including PODIUM SESSION at ISPOR-EU 2022

NOVEL was selected for 13 Presentations, including PODIUM Session. Topics cover evidence generation needs for diagnostics, PDTs, RWE, orphan drugs, oncology, IBD, mucosal healing, ALS, advanced modeling methods and other HEOR topics! ISPOR Announcements



Saurabh (Rob) Aggarwal, PhD,

Principal & Co-Founder